Clinical Trial Update: Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [NA]

View source ↗

Summary

This document reports a terminated clinical trial evaluating epoetin alfa for chemotherapy-related anemia in cancer patients, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Drugs mentioned

• Epogen (epoetin alfa)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Anemia, Fatigue | NA | Status: TERMINATED | Results posted: 2011-05-26